TruBridge (NASDAQ:TBRG) Major Shareholder Buys $383,014.59 in Stock

TruBridge, Inc. (NASDAQ:TBRG) major shareholder Pinetree Capital Ltd. purchased 18,933 shares of TruBridge stock in a transaction dated Friday, November 14th. The shares were acquired at an average cost of $20.23 per share, for a total transaction of $383,014.59. Following the transaction, the insider directly owned 817,153 shares of the company’s stock, valued at approximately $16,531,005.19. This represents a 2.37% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Pinetree Capital Ltd. also recently made the following trade(s):

• On Thursday, November 13th, Pinetree Capital Ltd. bought 21,035 shares of TruBridge stock. The stock was bought at an average cost of $20.41 per share, for a total transaction of $429,324.35.
• On Wednesday, November 12th, Pinetree Capital Ltd. acquired 8,935 shares of TruBridge stock. The stock was bought at an average price of $19.94 per share, with a total value of $178,163.90.

TruBridge Trading Down 0.2%

NASDAQ:TBRG opened at $20.37 on Monday. The company has a market capitalization of $305.73 million, a PE ratio of -24.25 and a beta of 0.57. TruBridge, Inc. has a 52-week low of $15.40 and a 52-week high of $32.00. The stock’s 50 day moving average price is $20.10 and its 200 day moving average price is $21.68. The company has a quick ratio of 1.79, a current ratio of 1.80 and a debt-to-equity ratio of 0.94.

TruBridge (NASDAQ:TBRG) last released its quarterly earnings results on Thursday, November 6th. The company reported $0.88 EPS for the quarter, beating the consensus estimate of $0.40 by $0.48. TruBridge had a negative net margin of 3.63% and a positive return on equity of 3.30%. The firm had revenue of $86.11 million during the quarter, compared to the consensus estimate of $85.56 million. TruBridge has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. On average, research analysts anticipate that TruBridge, Inc. will post 0.07 EPS for the current year.

Institutional Investors Weigh In On TruBridge

Several institutional investors have recently modified their holdings of TBRG. Kingsview Wealth Management LLC purchased a new position in TruBridge in the 1st quarter valued at approximately $240,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in TruBridge in the first quarter valued at $370,000. Jefferies Financial Group Inc. purchased a new position in shares of TruBridge in the first quarter valued at $256,000. Vanguard Group Inc. raised its stake in shares of TruBridge by 2.6% during the 1st quarter. Vanguard Group Inc. now owns 663,862 shares of the company’s stock worth $18,269,000 after buying an additional 16,715 shares during the last quarter. Finally, Invesco Ltd. raised its stake in shares of TruBridge by 177.7% during the 1st quarter. Invesco Ltd. now owns 151,489 shares of the company’s stock worth $4,169,000 after buying an additional 96,931 shares during the last quarter. Hedge funds and other institutional investors own 88.64% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have issued reports on TBRG shares. Weiss Ratings reissued a “sell (e+)” rating on shares of TruBridge in a research note on Friday, October 31st. BMO Capital Markets initiated coverage on shares of TruBridge in a research note on Thursday. They set a “market perform” rating and a $19.50 price target on the stock. One analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, TruBridge has an average rating of “Hold” and a consensus price target of $25.50.

TruBridge Company Profile

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.